» Articles » PMID: 19736558

Quercetin in an Animal Model of Spinal Cord Compression Injury: Correlation of Treatment Duration with Recovery of Motor Function

Overview
Journal Spinal Cord
Specialty Neurology
Date 2009 Sep 9
PMID 19736558
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We have shown previously that administration of quercetin after spinal cord injury in a rat model induced significant recovery of motor function. In the same model for spinal cord compression injury, we now have correlated the treatment duration with the extent to which motor function is recovered.

Methods: Seventy-four male Wistar rats were assigned to eight experimental groups. Mid-thoracic spinal cord injury was produced in the animals of seven groups. Quercetin was administered intraperitoneally in individual doses of 25 micromol kg(-1). Treatment onset was 1 h after the injury. The length of treatment ranged from one single injection to 10 days, with injection frequencies of two or three times daily. BBB (Basso, Beattie and Bresnahan) scores were obtained and tissue preservation at the site of injury was analyzed.

Results: None of the untreated control animals recovered motor function sufficient to walk. When quercetin was administered twice daily over a period of either 3 or 10 days, about 50% of the animals recovered sufficient motor function to walk. Stepping/walking (BBB > or =10) were seen in two of six animals receiving only a single injection and in one of the six animal receiving three injections. Surprisingly, none of the animals that received quercetin injections three times daily recovered the ability to walk (all BBB < or = 9).

Conclusion: Quercetin administration results in preservation of tissue bridges at the site of injury. Treatment success depends on frequency of administration and overall dose.

Citing Articles

Pharmacological Network Analysis of the Functions and Mechanism of Quercetin From Jisuikang (JSK) in Spinal Cord Injury (SCI).

Dong L, He H, Chen Z, Wang X, Li Y, Lu G J Cell Mol Med. 2024; 28(24):e70269.

PMID: 39679746 PMC: 11648003. DOI: 10.1111/jcmm.70269.


Tempol, a Superoxide Dismutase Mimetic, Inhibits Wallerian Degeneration Following Spinal Cord Injury by Preventing Glutathione Depletion and Aldose Reductase Activation.

Zeman R, Brown A, Wen X, Ouyang N, Etlinger J J Neurotrauma. 2024; 41(17-18):2186-2198.

PMID: 39083435 PMC: 11807894. DOI: 10.1089/neu.2024.0137.


Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update.

Abdelsalam S, Renu K, Abu Zahra H, Abdallah B, Ali E, Veeraraghavan V Nutrients. 2023; 15(5).

PMID: 36904106 PMC: 10005012. DOI: 10.3390/nu15051107.


Quercetin Derivatives in Combating Spinal Cord Injury: A Mechanistic and Systematic Review.

Fakhri S, Gravandi M, Abdian S, Moradi S, Echeverria J Life (Basel). 2022; 12(12).

PMID: 36556325 PMC: 9783198. DOI: 10.3390/life12121960.


Quercetin Can Improve Spinal Cord Injury by Regulating the mTOR Signaling Pathway.

Wang X, Fu Y, Botchway B, Zhang Y, Zhang Y, Jin T Front Neurol. 2022; 13:905640.

PMID: 35669881 PMC: 9163835. DOI: 10.3389/fneur.2022.905640.